image: Stephen Kingsmore, MD, DSc, President and CEO or Rady Children's Institute for Genomic Medicine view more
Credit: Rady Children's Institute for Genomic Medicine
SAN DIEGO, Calif. – June 27, 2022 – Rady Children's Institute for Genomic Medicine® (RCIGM) today announced that Stephen Kingsmore, MD, DSc, President and CEO, will receive the 2022 Luminary Award at the Precision Medicine World Conference (PMWC) to be held from June 28 to 30 in the Silicon Valley region of California.
The Luminary Award recognizes the recent contributions of prominent figures who have accelerated precision medicine into the clinic. Dr. Kingsmore will be recognized for his innovation in rapid neonatal molecular diagnoses using whole-genome sequencing. Additional PMWC 2022 honorees will include Dr. Albert Bourla from Pfizer and Dr. Stephen Hoge from Moderna.
RCIGM at PMWC:
• On Wednesday, June 29, at 9 a.m., PST, Dr. Kingsmore will received the Luminary Award in a brief presentation by Martin Reese Ph.D., Co-Founder, CEO, Pres., Fabric Genomics.
• Then at 9:15 a.m., PST, Dr. Kingsmore will speak on “NICU Current State and Future of Whole Genome Sequencing” as part of the Track 4 program, “Sequencing in the Neonatal and Pediatric Intensive Care Unit.” Dr. Kingsmore will be present to receive his award at this time.
• Later at 11:15 a.m. PST, Russell Nofsinger, PhD, Senior Director of Business Development at RCIGM, will present on “Partnerships to End the Diagnostic and Therapeutic Odysseys “ during the “Clinical DX Showcase.”
• RCIGM will also host Booth #C1626 Hall C, Track 3, from June 28-30 during regular conference hours.
Rady Children’s Institute for Genomic Medicine
Rady Children’s Institute for Genomic Medicine is transforming neonatal and pediatric health care by harnessing the power of Rapid Precision Medicine™ to improve the lives of children and families facing rare genetic disease. Founded by Rady Children’s Hospital and Health Center, the Institute offers the fastest delivery of rapid Whole Genome Sequencing™ to enable prompt diagnosis and targeted treatment of critically ill newborns and children in intensive care. The Institute now provides clinical genomic diagnostic services for a growing network of more than 70 children’s hospitals. The vision is for this life-changing technology to become standard of care and enable clinicians nationwide to provide rapid, personalized care. Learn more about the non-profit Institute at RadyGenomics.org. Follow us on Twitter and LinkedIn.
###